You have 9 free searches left this month | for more free features.

City

Condition

EGFR Mutation-Related Tumors (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Nalo Therapeutics Inc. (1)

Collaborator

Intervention

nx-019 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

nx-019

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

EGFR Mutation-Related Tumors Trial (NX-019)

Not yet recruiting

EGFR Mutation-Related Tumors

NX-019

(no location specified)

Aug 22, 2022